Clot permeability linked to first-attempt success of aspiration thrombectomy

August 11, 2020

TAMPA, Fla. (Aug. 10, 2020) - In certain patients suffering a severe ischemic stroke, a mechanical device can be used to remove a clot blocking blood flow to the brain. The minimally invasive procedure either suctions the clot directly out of a large artery to the brain (known as aspiration thrombectomy), or by grabbing and extracting the blockage with a stent (stent-retrieval thrombectomy). Last year, a major trial known as COMPASS found both catheter-guided techniques to be equally safe and effective as first-line approaches for treating emergent large vessel occlusions (ELVO), the most destructive type of ischemic stroke.

Now, a multicenter study led by the University of South Florida Health (USF Health) Department of Neurosurgery and Tampa General Hospital, reports that clot perviousness, or permeability - the ability for contrast used during the initial imaging workup to seep through a clot, as estimated by CT imaging - is associated with "first-pass success" in ELVO patients initially treated with the aspiration thrombectomy approach.

Findings from this posthoc analysis of 165 eligible patients enrolled in the COMPASS trial were published July 17 in theJournal of Neurointerventional Surgery.

First-pass success means achieving complete reopening of a blocked artery in the first attempt with a thrombectomy device. The treatment success of the stent retriever-first approach for a large vessel occlusion stroke was less dependent on clot perviousness, the study found. Time-sensitive, successful removal of the clot restores blood flow (and therefore oxygen) to the brain, improving the likelihood of faster stroke recovery and reduced complications and disability.

The data is the first to indicate that highly pervious clots may result in better treatment success after first attempt clot removal using the aspiration thrombectomy technique. However, clots with low perviousness are more resistant to either thrombectomy approach, the researchers report, and more research is needed to determine the most effective way to treat ELVO in this population of patients.

"Currently, physicians who treat strokes with thrombectomy are 'in the dark.' We have a variety of tools available but, frankly, we often don't know which particular device will be most effective in a particular patient," said the paper's lead author Max Mokin, MD, PhD, associate professor of neurosurgery and neurology at the USF Health Morsani College of Medicine and Tampa General Hospital. "This study provides the first set of clues to guide us in selecting the devices (aspiration and/or stent retrievers) that may provide the most advantage, making the thrombectomy procedure safer, faster and ultimately more effective."

Dr. Mokin specializes in neurointerventional surgery for the USF Health and Tampa General Hospital, one of the largest academic medical centers in Florida. He leads a three-year National Institutes of Health grant investigating how patient brain vessel anatomy interacts with clot removal devices. The goal is to optimize endovascular approaches for treating acute ischemic stroke, a leading cause of death and long-term disability worldwide.

University of South Florida (USF Health)

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to